Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Siloam International Hospitals Tbk. (SILO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Siloam International Hospitals Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Siloam International Hospitals Tbk. trades at Rp2,190 (market cap 28.61T, 60.3K 24h volume). The key difference: Siloam International Hospitals Tbk. is far larger — about 92.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 60.3K). Which is the better fit depends on your goals.
| DGNS | SILO | |
|---|---|---|
Market Cap | 310.75B | 28.61T |
Volume | 963.6K | 60.3K |
Lot | 9.64K | 603 |
Turnover | 217.67M | 132.38M |
Average Price | 225.89 | 2,195.41 |
Value | 217.67M | 132.38M |
Indicative Equilibrium Price | 226 | 2,190 |
Indicative Equilibrium Volume | 1K | 11 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Siloam International Hospitals Tbk.
PT Siloam International Hospitals Tbk (the Company) was established under its original name of PT Sentralindo Wirasta on August 3, 1996. The Company started commercial operations in 2010 after the restructuring of the hospital unit of PT Lippo Karawaci Tbk.
Read more on SILO →
